Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- lesões escamosas maculopapulares eritematosas em formato de disco
- idade de 20 a 40 anos
- história de exposição à luz ultravioleta
- história de tabagismo
Другие диагностические факторы
- ausência de prurido e/ou dor
- telangiectasia, hiperpigmentação e/ou hipopigmentação
- alopecia cicatricial permanente
- características sistêmicas (artrite, pleurite, pericardite, convulsões, psicose)
Факторы риска
- idade de 20 a 40 anos
- exposição à luz ultravioleta
- tabagismo
- sexo feminino
- lesão cutânea inespecífica
Диагностические исследования
Исследования, которые показаны в первую очередь
- fatores antinucleares, ácido desoxirribonucleico (DNA) de fita dupla (ds)
- Hemograma completo
- Velocidade de hemossedimentação (VHS)
- ureia e eletrólitos
- urinálise
Исследования, проведение которых нужно рассмотреть
- biópsia de pele
Алгоритм лечения
doença localizada/limitada não grave
doença localizada/limitada grave ou refratária; doença disseminada
Составители
Авторы
Meng May Chee, MBChB, MRCP
Consultant Rheumatologist
Wishaw General Hospital
Wishaw
UK
Раскрытие информации
MMC declares that she has no competing interests.
Girish Gupta, MBChB, FRCP
Consultant Dermatologist
Lauriston Building
NHS Lothian
Edinburgh
UK
Раскрытие информации
GG is an advisory board member of Almirall, Galderma, and Viatris. GG has also been reimbursed for consultancy work by Almirall, Galderma, and AbbVie, and has received honoraria from Almirall, Galderma, Viatris, and La Roche-Posay for giving lectures.
Выражение благодарностей
Dr Meng May Chee and Dr Girish Gupta would like to gratefully acknowledge Dr Rajan Madhok, the previous contributor to this topic.
Раскрытие информации
RM declared holding shares in GSK to the value of less than £12,000.
Рецензенты
Jeffrey P. Callen, MD
Professor of Medicine (Dermatology)
University of Louisville
Louisville
KY
Раскрытие информации
JPC declares that he has no competing interests.
Mark Goodfield, MD
Consultant Dermatologist
Department of Dermatology
Leeds General Infirmary
Leeds
UK
Раскрытие информации
MG declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
O'Kane D, McCourt C, Meggitt S, et al; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. Br J Dermatol. 2021 Dec;185(6):1112-23.Полный текст Аннотация
Lu Q, Long H, Chow S, et al. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus. J Autoimmun. 2021 Sep;123:102707. Аннотация
Kuhn A, Aberer E, Bata-Csörgő Z, et al. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2017 Mar;31(3):389-404.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Отличия
- Lúpus eritematoso sistêmico (LES)
- Lúpus eritematoso cutâneo subagudo (LECS)
- Psoríase
Больше ОтличияРекомендации
- Guideline for vaccinations in patients with rheumatic and musculoskeletal diseases
- Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
Больше РекомендацииЛифлеты для пациента
Psoríase: quais são as opções de tratamento?
Psoríase: o que é?
Больше Лифлеты для пациентаВойдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности